Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis

An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)

(2018) Shin-Wha Lee et al.   Cancer Research and Treatment

Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer—The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial

(2018) Luca Gianni et al.   JAMA Oncology

Nano based drug delivery systems: recent developments and future prospects

(2018) Jayanta Kumar Patra et al.   JOURNAL OF NANOBIOTECHNOLOGY

An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer

(2017) In Hae Park et al.   Cancer Research and Treatment

Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study

(2016) Minish M. Jain et al.   BREAST CANCER RESEARCH AND TREATMENT

Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial

(2016) Michael Untch et al.   LANCET ONCOLOGY

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)

(2015) Hope S. Rugo et al.   JOURNAL OF CLINICAL ONCOLOGY

Predicting paclitaxel-induced neutropenia using the DMET platform

(2015) Annemieke JM Nieuweboer et al.   PHARMACOGENOMICS

A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)

(2014) A. Awada et al.   ANNALS OF ONCOLOGY

Clinical Comparison between Paclitaxel Liposome (Lipusu®) and Paclitaxel for Treatment of Patients with Metastatic Gastric Cancer

(2013) Xu Xu et al.   Asian Pacific Journal of Cancer Prevention

Paclitaxel-Loaded Polymeric Micelle (230 mg/m2) and Cisplatin (60 mg/m2) vs. Paclitaxel (175 mg/m2) and Cisplatin (60 mg/m2) in Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase IIB Trial

(2013) Sung Yong Lee et al.   Clinical Lung Cancer

A multicenter phase II randomized study of Cremophor-free polymeric nanoparticle formulation of paclitaxel in women with locally advanced and/or metastatic breast cancer after failure of anthracycline

(2012) Anantbhushan A Ranade et al.   Asia-Pacific Journal of Clinical Oncology

Liposomal paclitaxel formulations

(2012) Štěpán Koudelka et al.   JOURNAL OF CONTROLLED RELEASE

Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer

(2010) Silverio Tomao   International Journal of Nanomedicine

Superior efficacy of a Cremophor-free albumin-bound paclitaxel compared with solvent-based paclitaxel in Chinese patients with metastatic breast cancer

(2009) Zhong-Zhen GUAN et al.   Asia-Pacific Journal of Clinical Oncology

Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

(2009) Corey J. Langer et al.   Journal of Thoracic Oncology

Polymer-drug conjugates: Recent development in clinical oncology

(2008) Chun Li et al.   ADVANCED DRUG DELIVERY REVIEWS

The Efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following Carboplatin and Paclitaxel combination chemotherapy for non-small cell lung cancer

(2008) Tsutomu Yoshida et al.   SUPPORTIVE CARE IN CANCER